Nifedipine medications are calcium channel blockers used to treat hypertension and angina. They are capable of relaxing and widening blood vessels to allow increased blood flow and oxygen to the heart. With increasing life expectancy and demographic shifts towards an aging population, the needs for managing cardiovascular conditions are growing significantly. The global Nifedipine Medication Market is estimated to be valued at US$ 1260.52 Bn in 2024 and is expected to exhibit a CAGR of 9.4 % over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The growing geriatric population has been a key driver of the nifedipine medication market over the past decade. Population aging is widespread across the globe, with people aged 65 years or over representing the fastest growing segment of the population in developed and developing countries alike. Older individuals are more prone to develop cardiovascular diseases such as hypertension and angina due to aging physiological changes in the cardiovascular system. The number of people with such conditions has increased dramatically with the rise in life expectancy. This has significantly spurred the demand for effective and long-term medication options for management of cardiovascular diseases, such as nifedipine formulations. The market is expected to witness further growth over the forecast period owing to continued growth of the geriatric demographic globally.

Key Takeaways
The Global Nifedipine Medication Market Demand is expected to witness high growth during the forecast period of 2024 to 2031 supported by a rising geriatric population and increasing prevalence of hypertension. The market size for 2024 is estimated to be US$ 1260.52 Bn.

Regional analysis reveals that North America dominates the global nifedipine medication market currently owing to developed healthcare infrastructure and awareness levels. However, Asia Pacific is anticipated to grow at the fastest pace due to growing medical needs of expanding economies like India and China.

Key players operating in the nifedipine medication market are AB Volvo, Scania AB, Continental AG, Peloton Technology, and Daimler AG among others. These companies are focusing on product innovation and market expansion strategies to strengthen their positions.

For more details on the report, Read- https://www.trendingwebwire.com/nifedipine-medication-market-growth-market-size-share-analysis/

Get more insights on this topic: https://www.ukwebwire.com/neurological-biomarkers-market-trends-size-and-share-analysis-2/